Veterinary Rabies Vaccine Supply (Commercial Off-the-Shelf)

The contract entails the supply of pre-manufactured veterinary rabies vaccine in full compliance with federal and Defense Logistics Agency specifications, ensuring the product meets all required safety, efficacy, and regulatory standards without the need for any assembly, modification, or field service. The vaccine is classified as a commercial off-the-shelf item, indicating it is an off-the-shelf product readily available from the market, procured as-is for immediate use. The North American Industry Classification System code 325414 identifies the provider as engaged in pharmaceutical and biological product manufacturing, affirming the specialized nature of the product and its producer. This subcontract, issued under the Department of Defense through the Defense Logistics Agency, was posted on June 24, 2026, and is intended for delivery to designated federal recipients without requirement for on-site support or technical intervention. The place of performance and point of contact details are not specified, suggesting the delivery is logistics-managed centrally, with no geographic constraints on where the vaccine will be distributed. The absence of a solicitation number and set-aside designation indicates a direct procurement likely under existing framework agreements, emphasizing efficiency and readiness in fulfilling critical veterinary health needs for federal programs.